secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001193125-24-249124
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TScan Therapeutics expands leased space by ~25,628 sq ft at Waltham HQ through 2029
--------------------------------------------------------------------------------

- Lease amendment adds 25,628 rentable sq ft to existing 25,472 sq ft at 830 Winter St, Waltham, MA.
- New term runs from Q4 2024 to Oct 31, 2029; initial monthly base rent $163,378.50.
- Rent escalates annually: $168,279.86 (yr 2), $173,328.25 (yr 3), $178,528.10 (yr 4), $183,883.94 (yr 5).
- Landlord provides tenant improvement allowance of up to ~$2,681,540.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312524249124/0001193125-24-249124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312524249124/d891090d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-249124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer